Abu Dhabi Growth Fund: Neumora Therapeutics Raises $112M in Series B Financing

Neumora Therapeutics, a Watertown, MA-based clinical-stage biotechnology company, raised $112M in Series B funding. The round was led by Abu Dhabi Growth Fund, Altitude Life Science Ventures, Amgen, ARCH Venture Partners, Exor Ventures, F-Prime Capital, Invus, Mubadala Capital, Newpath Partners, and Polaris Partners. Alaa Halawa, partner and head of U.S. Ventures at Mubadala Capital, joined [...]The post Neumora Therapeutics Raises $112M in Series B Financing appeared first on FinSMEs.